Literature DB >> 1543537

Okadaic acid induces the expression of both early and secondary response genes in mouse keratinocytes.

K Holladay1, H Fujiki, G T Bowden.   

Abstract

Okadaic acid (OA), a potent mouse skin tumor promoter and inhibitor of the protein phosphatases 1 and 2A, was investigated for its effects on the expression of tumor-associated early and secondary response genes in mouse keratinocytes. Adult mice were treated topically with 12.5 nmol of OA, and the steady-state levels of various gene transcripts in the skin were determined at different times after treatment. The nuclear proto-oncogenes c-fos and c-jun are referred to as early response genes because the classical tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) induces their expression to maximal levels within 2 h after treatment. OA induced the expression of c-fos 2-72 h after treatment, with two peaks at 6 and 48 h. The steady-state level of expression of c-jun was relatively high in untreated skin, and OA induced a slight increase in its expression from 12 to 48 h after treatment. Transin and plasminogen-activator (PA) urokinase, whose induced expression peaks at least 4 h after TPA treatment, are referred to as secondary response genes. OA induced their expression more slowly than TPA. In mouse papilloma cell line 308, OA induced higher and more sustained steady-state levels of c-jun and c-fos than an equimolar dose of TPA. Transin and PA-urokinase were induced to similar levels by TPA and OA in 308 cells; however, the induction of these genes by OA was slower than induction by TPA. The existence of different patterns of induced expression of early and secondary response genes by OA and TPA suggests that these tumor promoters affect gene expression in mouse keratinocytes through different pathways.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1543537     DOI: 10.1002/mc.2940050106

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  12 in total

1.  Proteinase inhibitors I and II from potatoes specifically block UV-induced activator protein-1 activation through a pathway that is independent of extracellular signal-regulated kinases, c-Jun N-terminal kinases, and P38 kinase.

Authors:  C Huang; W Y Ma; C A Ryan; Z Dong
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 2.  The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.

Authors:  A Rietz; Jp Spiers
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Calcium regulation of keratinocyte differentiation.

Authors:  Daniel D Bikle; Zhongjian Xie; Chia-Ling Tu
Journal:  Expert Rev Endocrinol Metab       Date:  2012-07

4.  Expression of the tumor necrosis factor alpha gene and early response genes by nodularin, a liver tumor promoter, in primary cultured rat hepatocytes.

Authors:  E Sueoka; N Sueoka; S Okabe; T Kozu; A Komori; T Ohta; M Suganuma; S J Kim; I K Lim; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

5.  Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid.

Authors:  C Huang; W Y Ma; M I Dawson; M Rincon; R A Flavell; Z Dong
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

6.  Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.

Authors:  M Suganuma; S Okabe; E Sueoka; R Nishiwaki; A Komori; N Uda; K Isono; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Okadaic acid regulation of the retinoblastoma gene product is correlated with the inhibition of growth factor-induced cell proliferation in mouse fibroblasts.

Authors:  T A Kim; B R Velasquez; C E Wenner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

8.  Increase of labeling indices in gastrointestinal mucosae of mice and rats by compounds of the okadaic acid type.

Authors:  H Yuasa; K Yoshida; H Iwata; H Nakanishi; M Suganuma; M Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

9.  Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding.

Authors:  Rita Villanueva; Néstor Morales-Peza; Irma Castelán-Sánchez; Enrique García-Villa; Rocio Tapia; Angel Cid-Arregui; Alejandro García-Carrancá; Esther López-Bayghen; Patricio Gariglio
Journal:  BMC Cancer       Date:  2006-08-31       Impact factor: 4.430

10.  Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.

Authors:  L C Meade-Tollin; P Boukamp; N E Fusenig; C P Bowen; T C Tsang; G T Bowden
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.